Biomedicine & Biotech

Research and breakthroughs at the intersection of biology and medicine — from gene editing and synthetic biology to clinical trials, diagnostics, and the science driving next-generation therapies.

Podcast: Paxlovid's Waning Efficacy? Epoch Times' Anti-Glyphosate Hysteria Debunked

Podcast: Paxlovid's Waning Efficacy? Epoch Times' Anti-Glyphosate Hysteria Debunked
Join ACSH directors of bio-sciences and chemistry, Cameron English and Dr. Josh Bloom, as they break down these stories:
Read more

Paxlovid Doesn't Prevent You From Catching COVID. Here's Why That's Good News.

Paxlovid Doesn't Prevent You From Catching COVID. Here's Why That's Good News.
Pre-exposure prophylaxis (PrEP) is one of several historic breakthroughs in the four-decade battle against HIV/AIDS.
Read more

Plant-Based Vaccines? Medicago's COVID Shot Leads the Way

Plant-Based Vaccines? Medicago's COVID Shot Leads the Way
Just under two years ago, Canadian biotech firm Medicago began developing a plant-based COVID-19 vaccine.
Read more

Are COVID Vaccines Responsible for the Variants?

Are COVID Vaccines Responsible for the Variants?
Are COVID vaccines responsible for creating the multiple variants that keep hitting the world? I get this question all the time in the comments section following ACSH articles about vaccines.
Read more

Coming to a Drug Store Near You: mRNA Flu Vaccines?

Coming to a Drug Store Near You: mRNA Flu Vaccines?
The rapid development of mRNA-based COVID vaccines has sparked fresh interest in earlier efforts to produce new and hopefully more effective flu shots with the same technology.
Read more

COVID Vaccine Safety and VAERS: 4 Common Questions Answered

COVID Vaccine Safety and VAERS: 4 Common Questions Answered
Vaccine skepticism comes in many different varieties.
Read more

Killer COVID Vaccines? Yet Another Study Shows the Shots Are Safe

Killer COVID Vaccines? Yet Another Study Shows the Shots Are Safe
Since January, billions of COVID-19 vaccines have been administered around the world.
Read more

OY ... AY4.2 Delta. A New COVID Variant Shows Up. Should We Worry?

OY ... AY4.2 Delta. A New COVID Variant Shows Up. Should We Worry?
As if the Delta variant hasn't been a big enough pain in the a##, pretty much the last thing we need is an "improved" version.
Read more

Should Merck’s COVID Pill Be Granted Emergency Use Authorization?

Should Merck’s COVID Pill Be Granted Emergency Use Authorization?
There are now two direct-acting antiviral drugs that have been shown to decrease the severity of COVID, Gilead's remdesivir and Merck's molnupiravir.
Read more

Empiric Broad-Spectrum Antimicrobial Therapy is Here to Stay

Empiric Broad-Spectrum Antimicrobial Therapy is Here to Stay
Recent discussions on the economics of innovation in rapid diagnostic testing for bacterial infections in the hospital setting have inspired me to once again take pen (keyboard) in hand.
Read more
Subscribe to Biomedicine & Biotech
ACSH relies on donors like you. If you enjoy our work, please contribute.

Make your tax-deductible gift today!

 

 

Popular articles

ACSH Podcasts

Latest from Josh

Latest from Chuck